Ozempic and Wegovy appear to improve people's sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests. The active ingredient in the weight-loss medications, semaglutide, also appears to affect the way that the tongue and brain respond to sweet tastes, researchers reported Saturday at the Endocrine Society's annual meeting in Boston. "People with obesity often perceive tastes less 'intensely,' and they have an inherently elevated desire for ...